|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net loss | ||
| Formation and operating costs paid by Sponsor | ||
| Interest earned on cash held in Trust Account | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Formation and operating costs paid by Sponsor | ||
| Interest earned on investments held in Trust Account | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accrued offering costs and expenses | ||
| Income taxes payable | ||
| Due to related party | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Cash withdrawn from Trust Account for tax purposes | ||
| Investment of cash in Trust Account | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from initial public offering, net of underwriters’ discount | ||
| Proceeds from sale of founder shares | ||
| Proceeds from private placement units | ||
| Payment of promissory note - related party | ||
| Proceeds from reimbursement from underwriter | ||
| Repayment of advances from related party | ||
| Payment of other offering costs | ||
| Net cash (used in) provided by financing activities | ||
| Net change in cash | ||
| Net change in cash and cash equivalents | ||
| Cash and cash equivalents – Beginning of period | ||
| Cash and cash equivalents – End of period | ||
| Deferred underwriting payable charged to additional paid-in capital | ||
| Reimbursement receivable | ||
| Non-cash investing and financing activities: | ||
| Deferred underwriting payable charged to additional paid-in capital | ||
| Reimbursement receivable |
Loading...
